Cleared Traditional

K260041 - MDx-Chex for BCP (FDA 510(k) Clearance)

Mar 2026
Decision
80d
Days
Class 2
Risk

K260041 is an FDA 510(k) clearance for the MDx-Chex for BCP. This device is classified as a Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays (Class II - Special Controls, product code PMN).

Submitted by Streck, LLC (La Vista, US). The FDA issued a Cleared decision on March 27, 2026, 80 days after receiving the submission on January 6, 2026.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3920. Assayed External Quality Control Material To Monitor The Performance Of Microbiology Nucleic Acid Assays For In Vitro Diagnostic Use..

Submission Details

510(k) Number K260041 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 06, 2026
Decision Date March 27, 2026
Days to Decision 80 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PMN - Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3920
Definition Assayed External Quality Control Material To Monitor The Performance Of Microbiology Nucleic Acid Assays For In Vitro Diagnostic Use.